| 1. |
|
|
| 2. |
- Liu, Chengxi, et al.
(författare)
-
Investigating the impacts of weather variability on individual's daily activity-travel patterns : A comparison between commuters and non-commuters in Sweden
- 2015
-
Ingår i: Transportation Research Part A. - : Elsevier. - 0965-8564 .- 1879-2375. ; 82, s. 47-64
-
Tidskriftsartikel (refereegranskat)abstract
- Understanding travel behaviour change under various weather conditions can help analysts and policy makers incorporate the uniqueness of local weather and climate within their policy design, especially given the fact that future climate and weather will become more unpredictable and adverse. Using datasets from the Swedish National Travel Survey and the Swedish Meteorological and Hydrological Institute that spans a period of thirteen years, this study explores the impacts of weather variability on individual activity-travel patterns. In doing so, this study uses an alternative representation of weather from that of directly applying observed weather parameters. Furthermore, this study employs a holistic model structure. The model structure is able to analyse the simultaneous effects of weather on a wide range of interrelated travel behavioural aspects, which has not been investigated in previous weather studies. Structural equation models (SEM) are applied for this purpose. The models for commuters and non-commuters are constructed separately. The analysis results show that the effects of weather can be even more extreme when considering indirect effects from other travel behaviour indicators involved in the decision-making processes. Commuters are shown to be much less sensitive to weather changes than non-commuters. Variation of monthly average temperature is shown to play a more important role in influencing individual travel behaviour than variation of daily temperature relative to its monthly mean, whilst in the short term, individual activity-travel choices are shown to be more sensitive to the daily variation of the relative humidity and wind speed relative to the month mean. Poor visibility and heavy rain are shown to strongly discourage the intention to travel, leading to a reduction in non-work activity duration, travel time and the number of trips on the given day. These findings depict a more comprehensive picture of weather impact compared to previous studies and highlight the importance of considering interdependencies of activity travel indicators when evaluating weather impacts.
|
|
| 3. |
- Naver, L., et al.
(författare)
-
Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
- 2018
-
Ingår i: Infectious Diseases. - : Informa UK Limited. - 2374-4235 .- 2374-4243. ; 50:7, s. 495-506
-
Tidskriftsartikel (refereegranskat)abstract
- Prophylaxis and treatment with antiretroviral drugs have resulted in a very low rate of mother-to-child transmission (MTCT) of HIV during recent years. Registration of new antiretroviral drugs, modification of clinical praxis, updated general treatment guidelines and increasing knowledge about MTCT have necessitated regular revisions of the recommendations for Prophylaxis and treatment of HIV-1 infection in pregnancy'. The Swedish Reference Group for Antiviral Therapy (RAV) has updated the recommendations from 2013 at an expert meeting 19 September 2017. In the new text, current treatment guidelines for non-pregnant are considered. The most important revisions are that: (1) Caesarean section and infant prophylaxis with three drugs are recommended when maternal HIV RNA >150 copies/mL (previously >50 copies/mL). The treatment target of undetectable HIV RNA remains unchanged <50 copies/mL; (2) Obstetric management and mode of delivery at premature rupture of the membranes and rupture of the membranes at full term follow the same procedures as in HIV negative women; (3) Vaginal delivery is recommended to a well-treated woman with HIV RNA <150 copies/mL regardless of gestational age, if no obstetric contraindications are present; (4) Treatment during pregnancy should begin as soon as possible and should continue after delivery; (5) Ongoing well-functioning HIV treatment at pregnancy start should usually be retained; (6) Recommended drugs and drug combinations have been updated.
|
|
| 4. |
|
|
